HumanexaHumanexaHumanexa
WelcomeSignalsCompaniesAssetsScenario AnalysisRegulatoryStrategy
InsightsNewslettersReportsBriefings
Pricing
WorkspaceTeamWatchlistsCollectionsSettings

Free

Intelligence Active

Regunera

MHRA

Regulatory intelligence
MHRAsafety guidance72% confidence

Guidance: Warning statements for labels and leaflets of certain medicines

Source: MHRA

Why This Matters

Why this matters: illustrates how regulators handled a comparable safety guidance decision relevant to Apoquel.

Regulatory Analysis

This guidance sets out the warning statements which should appear on the label and/or in the leaflet of certain medicines.

Supporting Context

Therapeutic area
Veterinary Medicine · Allergy
Sub-indication
General

Related signal: FDA Reports Increase in Accidental Overdoses of Apoquel Chewable in Dogs

Source

View source document

Related Signal

Open signal — FDA Reports Increase in Accidental Overdoses of Apoquel Chewable in Dogs
PrivacyTermsRefund PolicyDisclaimerContact

© 2026 Humanexa. Intelligence for research workflows — not medical, legal, regulatory filing, or investment advice.